MORE►
ophthalmic optics company
Marketing image for one of Eyevance Pharmaceuticals' products, Flarex. [eyevance.com]
Fort Worth Ophthalmic Biotech Eyevance Exits to Japanese Firm for $225M
by Alex Edwards | Sep 17, 2020
Eyevance Pharmaceuticals, which develops and commercializes ophthalmic products, has been purchased for $225 million by Santen, a Japanese leader in ophthalmology. Eyevance will join Santen's U.S. organization.
by Heather Noel |
Mar 21, 2017
The French ophthalmic optics company with U.S. headquarters in Dallas, is leading a challenge to improve access to vision care.
MORE►
